Altimmune Inc (NASDAQ: ALT) is -15.64% lower on its value in year-to-date trading and has touched a low of $2.32 and a high of $14.84 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ALT stock was last observed hovering at around $7.35 in the last trading session, with the day’s gains setting it 2.14%.
Currently trading at $9.49, the stock is 33.54% and 37.71% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 18.46 million and changing 29.12% at the moment leaves the stock 24.15% off its SMA200. ALT registered 279.60% gain for a year compared to 6-month loss of 21.36%. The firm has a 50-day simple moving average (SMA 50) of $6.8291 and a 200-day simple moving average (SMA200) of $7.647275.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 47.59% gain in the last 1 month and extending the period to 3 months gives it a 53.56%, and is 34.99% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.41% over the week and 8.44% over the month.
Altimmune Inc (ALT) has around 59 employees, a market worth around $674.46M and $0.41M in sales. Profit margin for the company is -24778.97%. Distance from 52-week low is 309.94% and -36.05% from its 52-week high. The company has generated returns on investments over the last 12 months (-65.79%).
The EPS is expected to grow by 16.00% this year, but quarterly earnings will post -97.70% year-over-year.
Altimmune Inc (ALT) Top Institutional Holders
241.0 institutions hold shares in Altimmune Inc (ALT), with institutional investors hold 60.29% of the company’s shares. The shares outstanding are 70.68M, and float is at 70.48M with Short Float at 32.54%. Institutions hold 59.81% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 5.32 million shares valued at $35.39 million. The investor’s holdings represent 7.5155% of the ALT Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 4.91 million shares valued at $32.63 million to account for 6.9301 of the shares outstanding. The other top investors are STATE STREET CORP which holds 3.91 million shares representing 5.5215% and valued at over $26.0 million, while AMERIPRISE FINANCIAL INC holds 4.5536 of the shares totaling 3.22 million with a market value of $21.44 million.
Altimmune Inc (ALT) Insider Activity
The most recent transaction is an insider sale by Drutz David, the company’s Director. SEC filings show that Drutz David sold 16,011 shares of the company’s common stock on Aug 19 ’24 at a price of $6.90 per share for a total of $0.11 million. Following the sale, the insider now owns 41958.0 shares.
